Literature DB >> 26979970

Comment on: "Therapies to Preserve β-Cell Function in Type 1 Diabetes".

Devi Dayal1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26979970     DOI： 10.1007/s40265-016-0560-9

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  10 in total

1.  Cholecalciferol supplementation improves suppressive capacity of regulatory T-cells in young patients with new-onset type 1 diabetes mellitus - A randomized clinical trial.

Authors:  Gerlies Treiber; Barbara Prietl; Elke Fröhlich-Reiterer; Evelyne Lechner; Anja Ribitsch; Maria Fritsch; Birgit Rami-Merhar; Claudia Steigleder-Schweiger; Winfried Graninger; Martin Borkenstein; Thomas R Pieber
Journal:  Clin Immunol       Date:  2015-08-12       Impact factor: 3.969

2.  The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI).

Authors:  D Pitocco; A Crinò; E Di Stasio; S Manfrini; C Guglielmi; S Spera; G Beretta Anguissola; N Visalli; C Suraci; M C Matteoli; I P Patera; M G Cavallo; C Bizzarri; P Pozzilli
Journal:  Diabet Med       Date:  2006-08       Impact factor: 4.359

3.  Effect of cholecalciferol as adjunctive therapy with insulin on protective immunologic profile and decline of residual β-cell function in new-onset type 1 diabetes mellitus.

Authors:  Mônica A L Gabbay; Maria N Sato; Claudia Finazzo; Alberto J S Duarte; Sergio A Dib
Journal:  Arch Pediatr Adolesc Med       Date:  2012-07-01

4.  No effect of the 1alpha,25-dihydroxyvitamin D3 on beta-cell residual function and insulin requirement in adults with new-onset type 1 diabetes.

Authors:  Markus Walter; Thomas Kaupper; Kerstin Adler; Johannes Foersch; Ezio Bonifacio; Anette-G Ziegler
Journal:  Diabetes Care       Date:  2010-03-31       Impact factor: 19.112

Review 5.  Immune interventions to preserve β cell function in type 1 diabetes.

Authors:  Mario R Ehlers
Journal:  J Investig Med       Date:  2016-01       Impact factor: 2.895

6.  Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA).

Authors:  Xia Li; Lan Liao; Xiang Yan; Gan Huang; Jian Lin; Minxiang Lei; Xiangbing Wang; Zhiguang Zhou
Journal:  Diabetes Metab Res Rev       Date:  2009-07       Impact factor: 4.876

7.  Effect of 6-months' vitamin D supplementation on residual beta cell function in children with type 1 diabetes: a case control interventional study.

Authors:  Atindra Mishra; Devi Dayal; Naresh Sachdeva; Savita Verma Attri
Journal:  J Pediatr Endocrinol Metab       Date:  2016-04       Impact factor: 1.634

8.  No protective effect of calcitriol on beta-cell function in recent-onset type 1 diabetes: the IMDIAB XIII trial.

Authors:  Carla Bizzarri; Dario Pitocco; Nicola Napoli; Enrico Di Stasio; Daria Maggi; Silvia Manfrini; Concetta Suraci; Maria Gisella Cavallo; Marco Cappa; Giovanni Ghirlanda; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 19.112

9.  A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.

Authors:  Asal Ataie-Jafari; Seng-Cheong Loke; Asmah B Rahmat; Bagher Larijani; Farzaneh Abbasi; Melvin K S Leow; Zaitun Yassin
Journal:  Clin Nutr       Date:  2013-01-26       Impact factor: 7.324

Review 10.  Therapies to Preserve β-Cell Function in Type 1 Diabetes.

Authors:  Johnny Ludvigsson
Journal:  Drugs       Date:  2016-02       Impact factor: 11.431
  10 in total
  1 in total

1.  Author's Reply to Dayal: "Therapies to Preserve β-Cell Function in Type 1 Diabetes".

Authors:  Johnny Ludvigsson
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.